FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly cardiology, and concerns immune correction in patients with essential arterial hypertension. That is ensured by the integrated drug treatment added with Mexicor according to the following regimen: the intravenous drop-by-drop slow introduction in dose of 400 mg a day for 5 days, and the intramuscular introduction in dose of 100 mg 4 times a day for 10 days, and the oral introduction in capsules 100 mg 4 times a day for 8 weeks.
EFFECT: such empirically specified regimen provides the most effective correction of immune disorders in the given group of patients.
1 ex, 1 dwg
